Patents by Inventor Christian Hölscher

Christian Hölscher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neurological diseases
    Patent number: 11851468
    Abstract: Aspects and embodiments of the present invention relate to the treatment of neurological disorders such as for example, Alzheimers disease and Parkinsons disease. Particularly, certain embodiments relate to GIP/GLP-1 co-agonist peptides for use in the treatment of these two neurological disorders. Also included in the present invention are inter alia pharmaceutical compositions comprising the GIP/GLP-1 co-agonist peptides, together with methods of treating such disorders as well as other subject matter.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: December 26, 2023
    Assignee: University of Lancaster
    Inventor: Christian Hölscher
  • DETERMINING A COMPUTATIONAL EFFORT OF A VIRTUAL TEST
    Publication number: 20230174083
    Abstract: A computer-implemented method for determining a computational effort of a virtual test of a device for driving a motor vehicle at least partly autonomously includes: providing at least one parameter set of driving situation parameters and of configuration data of a first algorithm that performs the virtual test, wherein the virtual test performed by the first algorithm simulates the at least one parameter set of driving situation parameters, and wherein the result of the simulation is used to determine at least one further parameter set of driving situation parameters that is simulated in a subsequent iteration; applying a second algorithm to the at least one parameter set of driving situation parameters and the configuration data of the first algorithm; and outputting at least one numerical value that represents the computational effort of the virtual test.
    Type: Application
    Filed: February 25, 2022
    Publication date: June 8, 2023
    Inventors: Eduard Miller, Renate Loeffler, Patrick Bouillon, Sebastian Bannenberg, Christian Hoelscher
  • TREATMENT OF NEUROLOGICAL DISEASES
    Publication number: 20220033457
    Abstract: Aspects and embodiments of the present invention relate to the treatment of neurological disorders such as for example, Alzheimers disease and Parkinsons disease. Particularly, certain embodiments relate to GIP/GLP-1 co-agonist peptides for use in the treatment of these two neurological disorders. Also included in the present invention are inter alia pharmaceutical compositions comprising the GIP/GLP-1 co-agonist peptides, together with methods of treating such disorders as well as other subject matter.
    Type: Application
    Filed: October 13, 2021
    Publication date: February 3, 2022
    Inventor: Christian Hölscher
  • Treatment of neurological diseases
    Patent number: 11220534
    Abstract: Aspects and embodiments of the present invention relate to the treatment of neurological disorders such as for example, Alzheimer's disease and Parkinson's disease. Particularly, certain embodiments relate to GIP/GLP-1 co-agonist peptides for use in the treatment of these two neurological disorders. Also included in the present invention are inter alia pharmaceutical compositions comprising the GIP/GLP-1 co-agonist peptides, together with methods of treating such disorders as well as other subject matter.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: January 11, 2022
    Assignee: Lancaster University Business Enterprises Limited
    Inventor: Christian Hölscher
  • Treatment of neurological diseases
    Patent number: 11174302
    Abstract: Aspects and embodiments of the present invention relate to the treatment of neurological disorders such as for example, Alzheimer's disease and Parkinson's disease. Particularly, certain embodiments relate to GIP/GLP-1 co-agonist peptides for use in the treatment of these two neurological disorders. Also included in the present invention are inter alia pharmaceutical compositions comprising the GIP/GLP-1 co-agonist peptides, together with methods of treating such disorders as well as other subject matter.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: November 16, 2021
    Assignee: Lancaster University Business Enterprises Limited
    Inventor: Christian Hölscher
  • TREATMENT OF NEUROLOGICAL DISEASES
    Publication number: 20200079832
    Abstract: Aspects and embodiments of the present invention relate to the treatment of neurological disorders such as for example, Alzheimer's disease and Parkinson's disease. Particularly, certain embodiments relate to GIP/GLP-1 co-agonist peptides for use in the treatment of these two neurological disorders. Also included in the present invention are inter alia pharmaceutical compositions comprising the GIP/GLP-1 co-agonist peptides, together with methods of treating such disorders as well as other subject matter.
    Type: Application
    Filed: December 4, 2017
    Publication date: March 12, 2020
    Inventor: Christian Hölscher
  • Pharmaceutical Composition for Use in the Treatment of a Neurodegenerative Disease
    Publication number: 20190070265
    Abstract: The present invention refers to a pharmaceutical composition for use in the treatment of a neurodegenerative disease.
    Type: Application
    Filed: April 25, 2018
    Publication date: March 7, 2019
    Inventors: Sibylle Hess, Christian Hölscher
  • Pharmaceutical composition for use in the treatment of a neurodegenerative disease
    Patent number: 9987332
    Abstract: The present invention refers to a pharmaceutical composition for use in the treatment of a neurodegenerative disease.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: June 5, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Sibylle Hess, Christian Hölscher
  • PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
    Publication number: 20160354445
    Abstract: The present invention refers to a pharmaceutical composition for use in the treatment of a neurodegenerative disease.
    Type: Application
    Filed: May 4, 2016
    Publication date: December 8, 2016
    Inventors: Sibylle HESS, Christian HOELSCHER, Andrees BOEHME, Agnes MENUT, Laurent PRADIER, Veronique TAUPIN
  • Pharmaceutical composition for use in the treatment of a neurodegenerative disease
    Patent number: 9364519
    Abstract: The present application relates to a pharmaceutical composition for use in the prevention or/and treatment of a neurodegenerative disease, the composition comprising desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, adjuvant, or/and auxiliary substance. In addition, the present application relates to the use of the pharmaceutical composition for the treatment and prevention of a neurodegenerative disease.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: June 14, 2016
    Assignees: SANOFI-AVENTIS DEUTSCHLAND GMBH, UNIVERSITY OF ULSTER
    Inventors: Sibylle Hess, Christian Hoelscher, Andrees Boehme, Agnes Menut, Laurent Pradier, Veronique Taupin
  • PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
    Publication number: 20130116179
    Abstract: The present invention refers to a pharmaceutical composition for use in the treatment of a neurodegenerative disease.
    Type: Application
    Filed: September 4, 2012
    Publication date: May 9, 2013
    Applicants: UNIVERSITY OF ULSTER, SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Sibylle HESS, Christian HOELSCHER, Andrees BOEHME, Agnes MENUT, Laurent PRADIER, Veronique TAUPIN